Numerical Analysis for Seismic Behavior of a Slope Based on a Simple Cyclic Loading Model

A finite element simulation for dynamic centrifuge test of a slope is presented. The horizontal acceleration was applied to the base of the ground, and the response of the slope was measured. The residual deformation, accompanied with a clear slip surface, was observed after the testing. The main objective of this study is to investigate the validity of a new cyclic loading model, based on the strength parameters c - φ, and the G – γ, h - γ relationships. These features are thought to be very useful for practical usage

Disturbance in the protein landscape of cochlear perilymph in an Alzheimer’s disease mouse model

Fukuda M., Okanishi H., Ino D., et al. (2024) Disturbance in the protein landscape of cochlear perilymph in an Alzheimer’s disease mouse model. PLoS ONE 19, e0303375. https://doi.org/10.1371/journal.pone.0303375.Hearing loss is a pivotal risk factor for dementia. It has recently emerged that a disruption in the intercommunication between the cochlea and brain is a key process in the initiation and progression of this disease. However, whether the cochlear properties can be influenced by pathological signals associated with dementia remains unclear. In this study, using a mouse model of Alzheimer’s disease (AD), we investigated the impacts of the AD-like amyloid β (Aβ) pathology in the brain on the cochlea. Despite little detectable change in the age-related shift of the hearing threshold, we observed quantitative and qualitative alterations in the protein profile in perilymph, an extracellular fluid that fills the path of sound waves in the cochlea. Our findings highlight the potential contribution of Aβ pathology in the brain to the disturbance of cochlear homeostasis

Expression of myogenin, MyoD and MHC isoforms in regenerating skeletal muscle.

骨格筋再生過程におけるミオシン重鎖(MHC)アイソフォーム発現とmyogenin，MyoDタンパクの発現様式との関連性を検討するために，塩酸ブピバカインを用いてマウスヒラメ筋損傷モデルを作成し，損傷筋の再生過程を組織形態学的に確認すると同時に，再生各段階におけるMHCアイソフォームと，myogeninおよびMyoDタンパク発現を経時的に検索した．本研究における筋損傷は塩酸ブピバカインをマウス(C57BL/10SnSlc)のヒラメ筋に注入することで作成した．組織学的には，塩酸ブピバカイン投与後3日目で筋線維はほとんど消失し，処置後6日目で中心核を有する再生筋線維がかなり出現し，処置後28日目では対照群のものと同程度まで回復した．生化学的分析では，対照群ヒラメ筋はMHCⅠ(34．3±1．7%)とMHCⅡa(65．7±1．7%)で構成されていた．実験群ヒラメ筋ではMHCⅠは処置後14日目まで減少し，その後増加傾向を示し，処置後90日目では36．3±2．9%となった．また，正常ヒラメ筋では検出されない速筋型MHC(MHC Ⅱd，MHC Ⅱb)が処置後3日目から28日目まで検出された．Western blotを用いた分析では，myogeninタンパク正常ヒラメ筋（遅筋）で検出された一方，前脛骨筋（速筋）においては検出できなかった．実験群ヒラメ筋では，myogeninは対照群と比較して処置後３日目より増加し（3．1±0．5），処置後６日目でピークに達した（5．8±0．8）．それからmyogeninタンパクは徐々に減少していったが，処置後90日目においてもなお対照群ヒラメ筋の1．8倍の発現を維持し続けた．一方，MyoDタンパクは正常前脛骨筋において正常ヒラメ筋の3．3倍の発現が認められた．MyoDは処置後３日目で対照群ヒラメ筋と比較して5．4倍になりピークに達した．その後は徐々に減少し始めた．しかし処置後90日目においても2．2倍の発現があった．これらのことから筋の再生過程においては速筋タイプの筋細胞が出現するmyogeninとMyoDは衛星細胞の分化と筋の再生に密接に関係していることが示唆された．To investigate the precise mechanism of skeletal muscle cell regeneration, the changing pattern ofmyosin heavy chain(MHC)isoforms during the regenerating process was observed with relation to theactivation of myogenin and MyoD. In addition, histopathological observation of the damaged muscles wasperformed throughout the experiment.In this study, muscle damage was induced by intramuscular injection of bupivacaine hydrochloride in thesoleus muscle of mice (C57BL/10SnSc). In the light microscopic observation, muscle cells had almost disappeared at 3 days after bupivacainetreatment with severe inflammatory cell infiltration. At 6 days after treatment, a considerable number ofregenerating muscle cells containing centrally located nuclei appeared in the damaged soleus muscle. At28 days, these regenerating muscle cells showed almost the same appearance as the control muscle cellscontaining subsarcolemmal nuclei, although a small number of muscle cells with central nuclei were stillrecognized.In the biochemical analysis, control soleus muscles contained only MHC I (34.3±1.7 %)and MHC IIa(65.7±1.7 %). In the damaged muscles, MHC I was decreased toward 14 days after treatment, and thengradually increased. At 90 days, the contents of MHC I was finally recovered to 36.3±2.9 %.0 In addition,MHC IId and MHC IIb appeared in the damaged muscle from 3 to 28 days after treatment. However, theyhad disappeared at 90 days.Using western blot analysis, myogenin protein was recognized in the control soleus muscles (slow typemuscle), while the myogenin could not be found in the first type muscle of the anterior tibial muscle. Themyogenin contents increased to about three fold (3.1±0.5)at 3 days after treatment compared withthose of control muscles and reached the maximum level (5.8±0.8)at 6 days after treatment. Then, myogenin contents gradually decreased,although they still remained high (1.8 times)at the end of experiment (90 days after treatment). Incontrast to the myogenin protein, a high level (3.3 times)of MyoD protein was detected in the anteriortibial muscle compared with that of control soleus muscles. In the damaged soleus muscles, MyoDcontents reached a maximum level (5.4 times)at 3 days after treatment compared with that of controlsoleus muscles, and then gradually decreased toward the end of experiment. However, MyoD protein stillremained 2.2 times compared with that of control soleus muscles. These findings described above indicate that, 1)a property of fast type muscle cells appeared in theregenerating muscle cells during the regenerating process, and 2)myogenin and MyoD are closelyrelated to the differentiation of the satellite cells and regeneration of the skeletal muscle cells

The role of astrocytes during repair of cerebral infarction in mdx mice

様々な大きさのジストロフィンアイソフォーム(427kDa, 260kDa, 140kDa, 116kDa, 71-75kDa)が広く体内に存在していることはよく知られている.中枢神経系においては71-75kDaのDp71が著明に多く,毛細血管の内皮の基底膜に接しているアストロサイトの細胞質に局在することが報告されている.しかしながらDp71の機能についてはよくわかっていないことが多い.そこで今回,脳組織におけるDp71の役割を調べるために,コントロールマウス(wild-typeマウス)およびデュシャンヌ型筋ジストロフィーモデル動物であるmdxマウスを用いて実験的脳梗塞を作成し,その治癒過程を形態学的に観察した.また,GFAPおよびDp71に関して生化学的に分析をおこなった.HE染色およびGFAP免疫組織学的染色の結果から,形態学的にはmdxマウスとコントロールマウスの脳に違いは認められなかった.しかしながら,mdxマウスの脳において,Dp71の発現量がコントロールマウスよりも少ないことがわかった.またmdxマウスにおいて,脳梗塞の修復過程におけるアストロサイトの反応がコントロールマウスよりも弱いことがわかった.これらの結果から,mdxマウスの脳において,アストロサイトの機能,アストロサイトの血管新生に関わる機能の障害されていることが示唆された.It is now well known that dystrophin isoforms (427kDa, 260kDa, 140kDa, 116kDa, 71-75kDa) are widely distributed throughout our body. In the central nervous system a considerable amount of Dp71 (71-75kDa) is found in the perivascular cytoplasm of the astrocytes. However, the function of this dystrophin is still unknown. To investigate the role of Dp71 in the brain tissue, cerebral infarction was induced in the control (wide-type) mouse and mdx mouse which is known as an animal model of human muscle dystrophy (Duchenne type), and morphological changes of the infarcted area were observed during repair of the infarction. In addition, biochemical analysis of GFAP and Dp71 was carried out in the brain of the control and mdx mouse. In our present study, there were no differences in brain morphology between mdx and control mouse as revealed in H-E stain and GFAP immunohistochemistry. However, the Dp71 were smaller in quantity in the brain of the mdx mouse than that of the control mouse. The reaction of astrocytes during repair of serebral infarction was distinctly delayed in the mdx mouse compared with that of the control mouse. These findings suggest that the astrocytes in the brain of the mdx mouse are functionally impaired including perivascular cytoplasmic processes with relation to neo-vascularization

Function of skeletal muscle sarcoplasmic reticulum and expression of sarcoplasmic reticulum Ca2+-ATPase in right congestive heart failure rats

右心不全に伴って,速筋および遅筋の筋小胞体Ca2+取り込み能が減少するという仮説を検証した.右心不全は,モノクロタリン(30 ㎎/㎏)を投与することにより引き起こし,投与後4週で,長指伸筋およびヒラメ筋を両後肢から採取した.筋の疲労耐性は,連続的な強縮刺激を行うことにより測定した.長指伸筋では刺激開始1分後,ヒラメ筋では4分後の張力を測定し,初期値に対するそれらの割合を疲労の指標とした.長指伸筋およびヒラメ筋の疲労耐性は,右心不全群で有意に低下した.筋小胞体Ca2+取り込み速度は,Indo-Ⅰを付加したホモジネートで測定した.その結果,Ca2+取り込み速度は,長指伸筋で25.4%(p<0.01),ヒラメ筋で30.4%(p<0.05)低下した.このCa2+取り込み速度の低下は,筋小胞体Ca2+-ATPaseタンパク量の低下と一致した.筋小胞体Ca2+取り込み能の低下は,筋張力の低下を引き起こし,このCa2+ handlingの低下は,少なくとも右心不全による運動耐容能の低下の一因であろう.In this study, we investigated the hypothesis that right congestive heart failure (CHF) would impair sarcoplasmic reticulum (SR) Ca2+ uptake in skeletal fast- and slow-twitch muscles. To induce CHF, the rats were injected with monocrotalin (30 ㎎/㎏). After 4 weeks of injection, extensor digitorum longus (EDL) and soleus (SOL) muscles were sampled from both hind limbs. Muscle fatigue resistance was measured in vitro as the relative decline in force production of tetanic contraction induced by electrical stimulation over 1 and 4 min in EDL and SOL, respectively. Evaluation of fatigue characteristics showed that CHF significantly reduced fatigue resistance in both muscles under study.SR Ca2+uptake rate wasmeasured in vitro with Indo-I on muscle homogenates. As hypothesized, Ca2+uptake rate was decreasedby 25.4%(P < 0.01) and 30.4%(P < 0.05) in EDL and SOL, respectively. This decline in Ca22+uptake ratewas accompanied by an immunochemically determined decrease in SR Ca2+-ATPase protein. Taking intoaccount previous findings that the depressed SR Ca2+uptake leads to the reduce in muscle forceproduction, these results suggest that impaired SR Ca2+handling capacity in skeletal muscle may accountat least partly for deteriorations in exercise tolerance resulting from right CHF

Breastfeeding history and metabolic syndrome in parous women

Objective The aim of the present study was to investigate the associations between breastfeeding and the prevalence of metabolic syndrome in community-dwelling parous women and to clarify whether the associations depend on age. Methods The present cross-sectional study included 11,118 women, aged 35–69 years. Participants’ longest breastfeeding duration for one child and their number of breastfed children were assessed using a self-administered questionnaire, and their total breastfeeding duration was approximated as a product of the number of breastfed children and the longest breastfeeding duration. The longest and the total breastfeeding durations were categorized into none and tertiles above 0 months. Metabolic syndrome and cardiovascular risk factors (obesity, hypertension, dyslipidemia, and hyperglycemia) were defined as primary and secondary outcomes, respectively. Associations between breastfeeding history and metabolic syndrome or each cardiovascular risk factor were assessed using multivariable unconditional logistic regression analysis. Results Among a total of 11,118 women, 10,432 (93.8%) had ever breastfed, and 1,236 (11.1%) had metabolic syndrome. In participants aged <55 years, an inverse dose–response relationship was found between the number of breastfed children and the prevalence of metabolic syndrome; multivariable-adjusted odds ratios for 1, 2, 3, and ≥4 breastfed children were 0.60 (95% confidence interval [CI]: 0.31 to 1.17), 0.50 (95% CI: 0.29 to 0.87), 0.44 (95% CI: 0.24 to 0.84), and 0.35 (95% CI: 0.14 to 0.89), respectively. The longest and total breastfeeding durations of longer than 0 months were also associated with lower odds of metabolic syndrome relative to no breastfeeding history in participants aged <55 years. In contrast, all measures of breastfeeding history were not significantly associated with metabolic syndrome and cardiovascular risk factors in participants aged ≥55 years old. Conclusions Breastfeeding history may be related to lower prevalence of metabolic syndrome in middle-aged parous women

A Proposal for Practical Diagnosis of Renal Hypouricemia : Evidenced from Genetic Studies of Nonfunctional Variants of URAT1/SLC22A12 among 30,685 Japanese Individuals

Background: Renal hypouricemia (RHUC) is characterized by a low serum uric acid (SUA) level and high fractional excretion of uric acid (FEUA). Further studies on FEUA in hypouricemic individuals are needed for a more accurate diagnosis of RHUC. Methods: In 30,685 Japanese health-examination participants, we genotyped the two most common nonfunctional variants of URAT1 (NFV-URAT1), W258X (rs121907892) and R90H (rs121907896), in 1040 hypouricemic individuals (SUA ≤ 3.0 mg/dL) and 2240 individuals with FEUA data. The effects of NFV-URAT1 on FEUA and SUA were also investigated using linear and multiple regression analyses. Results: Frequency of hypouricemic individuals (SUA ≤ 3.0 mg/dL) was 0.97% (male) and 6.94% (female) among 30,685 participants. High frequencies of those having at least one allele of NFV-URAT1 were observed in 1040 hypouricemic individuals. Furthermore, NFV-URAT1 significantly increased FEUA and decreased SUA, enabling FEUA and SUA levels to be estimated. Conversely, FEUA and SUA data of hypouricemic individuals are revealed to be useful to predict the number of NFV-URAT1. Conclusions: Our findings reveal that specific patterns of FEUA and SUA data assist with predicting the number of nonfunctional variants of causative genes for RHUC, and can also be useful for practical diagnosis of RHUC even before genetic tests

Association of Dietary Acid Load with the Prevalence of Metabolic Syndrome among Participants in Baseline Survey of the Japan Multi-Institutional Collaborative Cohort Study

The association between dietary acid load and metabolic syndrome (MetS) has not been fully investigated. A cross-sectional study was performed on 14,042 men and 14,105 women (aged 35–69 years) who participated in a baseline survey of the Japan Multi-Institutional Collaborative Cohort study. Dietary acid load was assessed using the net-endogenous-acid-production (NEAP) score that is closely correlated with the rate of renal net acid excretion. MetS was diagnosed according to the Joint Interim Statement Criteria of 2009 using body-mass index instead of waist circumference. After adjusting for potential confounders, higher NEAP scores were associated with a significantly increased odds ratio (OR) of MetS, obesity, high blood pressure, and high fasting blood glucose. These associations remained significant after further adjustment for carbohydrate intake or two nutrient-pattern scores significantly associated with MetS. After adjustment for fiber, iron, potassium, and vitamin pattern scores, the OR of MetS for the highest quartile of NEAP scores, relative to the lowest quartile, was 1.25 (95% confidence interval 1.12–1.39). There was no significant interaction between sex, age, or body-mass index and NEAP. Higher dietary acid load was associated with a higher prevalence of MetS and several of its components, independently of carbohydrate intake or nutrient patterns